Home / Copyright
Copyright last update 03/08/2011
All materials posted on this website are subject to and protected by copyrights owned by Pro Pharma Communications International (PPCI). Copyright ©2011 Pro Pharma Communications International, Postbus 10001, BE-2400 Mol, Belgium. The reproduction, transmission or storage in any form or by any means either mechanical or electronic, including subscription, photocopying, recording or through an information storage and retrieval system of the whole or parts of the materials appearing on this website is prohibited without the express consent of PPCI.
Individuals may make single photocopies for personal non-commercial use without obtaining prior permission as long as the following copyright statement is contained in the reproduction, retransmission or reprinting of such a document or part thereof: Copyright ©2011 Pro Pharma Communications International. All rights reserved. Non-profit institutions such as hospitals are generally permitted to make copies of articles for research or teaching activities (including multiple copies for classrooms use) at no charge, provided that the institution obtains the prior consent from Pro Pharma Communications International. Prior to use, all requests for permission should be addressed to: editorial@gabionline.net All other reproduction, copy, retransmission or reprinting of all or part of any content found on this website is strictly prohibited. The names, trademarks, service marks, logos, and icons of PPCI, e.g. GaBI Online, appearing on this website as well as the 'look' and 'feel' of the website (including the colour combinations, button shapes, layout, design and all other graphic elements) are also PPCI trademarks and may not be used or reproduced without prior consent.
Generics News Research General
- Italy asked to comply with marketing rules for...Generics/News | Posted 03/02/2012
- Generics market to experience strong growth in...Generics/Research | Posted 03/02/2012
- Generic and biosimilar user fee recommendations...Generics/News | Posted 03/02/2012
- Watson expands in Asia with Ascent PharmahealthGenerics/News | Posted 27/01/2012
Biosimilars News Research General
- Amphastar and Watson launch biosimilar enoxaparinBiosimilars/News | Posted 03/02/2012
- Production of 24 biosimilars in Iran by 2012Biosimilars/News | Posted 03/02/2012
- Factors affecting market access of biosimilarsBiosimilars/Research | Posted 03/02/2012
- Sandoz starts phase III trials for biosimilar f...Biosimilars/News | Posted 27/01/2012




